{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:38Z","timestamp":1786996058518,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"am","delay-in-days":364,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA95662"],"award-info":[{"award-number":["R01 CA95662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC1 CA146596"],"award-info":[{"award-number":["RC1 CA146596"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC1 EB011001"],"award-info":[{"award-number":["RC1 EB011001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UrologyCare Foundation Research Scholar Program"},{"name":"Martin and Diane Trust Career Development Chair in Surgery"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.prro.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,14]],"date-time":"2018-04-14T11:58:19Z","timestamp":1523707099000},"page":"445-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP"],"prefix":"10.1016","volume":"8","author":[{"given":"Stephen A.","family":"Mihalcik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Chipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith M.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina M.","family":"Crociani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2018.04.007_bb0005","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Prostate Cancer (version 1, 2016). Volume 2015."},{"key":"10.1016\/j.prro.2018.04.007_bb0010","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2011.1333","article-title":"Prediction of erectile function following treatment for prostate cancer","volume":"306","author":"Alemozaffar","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.007_bb0015","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.juro.2013.09.040","article-title":"Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice","volume":"191","author":"Chipman","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","article-title":"Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors","volume":"76","author":"Szymanski","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.prro.2018.04.007_bb0025","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.prro.2018.04.007_bb0030","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.juro.2011.04.085","article-title":"Expanded prostate cancer index composite for clinical practice: development and validation of a practical health related quality of life instrument for use in the routine clinical care of patients with prostate cancer","volume":"186","author":"Chang","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0035","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2018.04.007_bb0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.10657","article-title":"Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era","volume":"95","author":"D'Amico","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2018.04.007_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.1999.17.1.168","article-title":"Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer","volume":"17","author":"D'Amico","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.007_bb0050","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","article-title":"Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer","volume":"280","author":"D'Amico","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.007_bb0055","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jnci\/90.10.766","article-title":"A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.prro.2018.04.007_bb0060","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1200\/JCO.1999.17.5.1499","article-title":"Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer","volume":"17","author":"Kattan","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.007_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.juro.2006.08.068","article-title":"Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram","volume":"177","author":"Steyerberg","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2012.11324.x","article-title":"An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011","volume":"111","author":"Eifler","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.prro.2018.04.007_bb0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.urology.2007.03.042","article-title":"Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005","volume":"69","author":"Makarov","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.prro.2018.04.007_bb0080","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2018.04.007_bb0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0090-4295(01)01441-8","article-title":"Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium","volume":"58","author":"Partin","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.prro.2018.04.007_bb0090","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-5347(17)35410-1","article-title":"The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer","volume":"150","author":"Partin","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0095","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.juro.2012.11.174","article-title":"Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ejca.2015.02.002","article-title":"Are we ready to predict late effects? A systematic review of clinically useful prediction models","volume":"51","author":"Salz","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2018.04.007_bb0105","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.juro.2008.01.106","article-title":"Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram","volume":"179","author":"Eastham","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.prro.2018.04.007_bb0110","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1111\/j.1743-6109.2010.01845.x","article-title":"Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: A proposal of a novel preoperative risk stratification","volume":"7","author":"Briganti","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.prro.2018.04.007_bb0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1464-410X.2011.10757.x","article-title":"Predicting erectile function outcome in men after radical prostatectomy for prostate cancer","volume":"110","author":"Kilminster","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.prro.2018.04.007_bb0120","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2008.18.6486","article-title":"Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function","volume":"27","author":"Chen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2018.04.007_bb0125","first-page":"109","article-title":"Clinical use of EPIC for clinical practice (EPIC-CP) to assess patient-reported prostate cancer quality of life following robot-assisted radical prostatectomy","volume":"197","author":"Wagner","year":"2017","journal-title":"JUrol"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018301309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850018301309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:20:43Z","timestamp":1761819643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850018301309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1879850018301309"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2018.04.007","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting erectile function following external beam radiation therapy or brachytherapy for prostate cancer using EPIC-CP","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}